Image below from Healius FY22 presentation. non-covid revenue was down on FY21.
Image below from ACL FY22 presentation. Non-covid revenue up 8% on FY21.
Market overreacting on HLS poor result. Obviously ACL wont produce the revenue & profits it did in FY22 but i think this is baked into the price & should pop on 1HY results. Let's see!!
- Forums
- ASX - By Stock
- target price and why
Image below from Healius FY22 presentation. non-covid revenue...
Featured News
Add ACL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.75 |
Change
0.010(0.27%) |
Mkt cap ! $752.8M |
Open | High | Low | Value | Volume |
$3.80 | $3.80 | $3.70 | $2.274M | 609.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 5739 | $3.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.75 | 8309 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 5533 | 3.740 |
8 | 40028 | 3.730 |
7 | 4831 | 3.720 |
6 | 34758 | 3.710 |
6 | 13268 | 3.700 |
Price($) | Vol. | No. |
---|---|---|
3.750 | 1125 | 16 |
3.760 | 8875 | 17 |
3.770 | 17361 | 11 |
3.780 | 12569 | 4 |
3.790 | 646 | 2 |
Last trade - 15.50pm 03/10/2024 (20 minute delay) ? |
Featured News
ACL (ASX) Chart |